|
Cell Cycle
Citations 51-60 of 231 total displayed.
|
Past content
(since May 2000):
|
Identification of glucocorticoid-response genes in children with acute lymphoblastic leukemia
- Stefan Schmidt, Johannes Rainer, Stefan Riml, Christian Ploner, Simone Jesacher, Clemens Achmüller, Elisabeth Presul, Sergej Skvortsov, Roman Crazzolara, Michael Fiegl, Taneli Raivio, Olli A. Jänne, Stephan Geley, Bernhard Meister, and Reinhard Kofler
Blood 2006; 107: 2061-2069.
[Abstract]
[Full text]
[PDF]
Antimyeloma activity of heat shock protein-90 inhibition
- Constantine S. Mitsiades, Nicholas S. Mitsiades, Ciaran J. McMullan, Vassiliki Poulaki, Andrew L. Kung, Faith E. Davies, Gareth Morgan, Masaharu Akiyama, Reshma Shringarpure, Nikhil C. Munshi, Paul G. Richardson, Teru Hideshima, Dharminder Chauhan, Xuesong Gu, Charles Bailey, Marie Joseph, Towia A. Libermann, Neal S. Rosen, and Kenneth C. Anderson
Blood 2006; 107: 1092-1100.
[Abstract]
[Full text]
[PDF]
Tyrosine phosphorylation modulates binding preference to cyclin-dependent kinases and subcellular localization of p27Kip1 in the acute promyelocytic leukemia cell line NB4
- Christian Kardinal, Marc Dangers, Angelika Kardinal, Alexandra Koch, Dominique Tobias Brandt, Teruko Tamura, and Karl Welte
Blood 2006; 107: 1133-1140.
[Abstract]
[Full text]
[PDF]
Hematopoietic stem cell exhaustion impacted by p18INK4C and p21Cip1/Waf1 in opposite manners
- Hui Yu, Youzhong Yuan, Hongmei Shen, and Tao Cheng
Blood 2006; 107: 1200-1206.
[Abstract]
[Full text]
[PDF]
IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G2/M-phase accumulation and apoptosis in multiple myeloma cells
- Thomas Strömberg, Simon Ekman, Leonard Girnita, Lina Y. Dimberg, Olle Larsson, Magnus Axelson, Johan Lennartsson, Ulf Hellman, Kristina Carlson, Anders Österborg, Karin Vanderkerken, Kenneth Nilsson, and Helena Jernberg-Wiklund
Blood 2006; 107: 669-678.
[Abstract]
[Full text]
[PDF]
Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas
- Roberto Piva, Roberto Chiarle, Andrea D. Manazza, Riccardo Taulli, William Simmons, Chiara Ambrogio, Valentina D'Escamard, Elisa Pellegrino, Carola Ponzetto, Giorgio Palestro, and Giorgio Inghirami
Blood 2006; 107: 689-697.
[Abstract]
[Full text]
[PDF]
KSHV viral cyclin inactivates p27KIP1 through Ser10 and Thr187 phosphorylation in proliferating primary effusion lymphomas
- Grzegorz Sarek, Annika Järviluoma, and Päivi M. Ojala
Blood 2006; 107: 725-732.
[Abstract]
[Full text]
[PDF]
PKC412 inhibits in vitro growth of neoplastic human mast cells expressing the D816V-mutated variant of KIT: comparison with AMN107, imatinib, and cladribine (2CdA) and evaluation of cooperative drug effects
- Karoline V. Gleixner, Matthias Mayerhofer, Karl J. Aichberger, Sophia Derdak, Karoline Sonneck, Alexandra Böhm, Alexander Gruze, Puchit Samorapoompichit, Paul W. Manley, Doriano Fabbro, Winfried F. Pickl, Christian Sillaber, and Peter Valent
Blood 2006; 107: 752-759.
[Abstract]
[Full text]
[PDF]
Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignancies
- Nelofer Syed, Paul Smith, Alexandra Sullivan, Lindsay C. Spender, Martin Dyer, Lorraine Karran, Jenny O'Nions, Martin Allday, Ingrid Hoffmann, Dorothy Crawford, Beverley Griffin, Paul J. Farrell, and Tim Crook
Blood 2006; 107: 250-256.
[Abstract]
[Full text]
[PDF]
KSHV G protein-coupled receptor inhibits lytic gene transcription in primary-effusion lymphoma cells via p21-mediated inhibition of Cdk2
- Mark Cannon, Ethel Cesarman, and Chris Boshoff
Blood 2006; 107: 277-284.
[Abstract]
[Full text]
[PDF]
|
|
